Cancer Vaccines

Merck Launches iChemoDiary, a Free Application Designed to Assist Care of Patients with Cancer Undergoing Chemotherapy

Published in Vaccine Weekly, November 18th, 2009

Merck & Co., Inc., announced the launch of iChemoDiary, a free first-of-its-kind application in the cancer therapeutic area designed to be used by care givers and patients with cancer undergoing chemotherapy. The application is now available on the Apple Store® (iTunes.com, application program-search on "iChemoDiary").

iChemoDiary is an interactive health diary that helps patients and caregivers record chemotherapy schedules, medications and treatment plans, and selected side effects of treatment. The application also provides patients with a tool to create reports that can be used in discussions with their doctor, nurse, or other health care providers. Patients...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (2009-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry